BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 17896127)

  • 1. Aspirin resistance in children with heart disease at risk for thromboembolism: prevalence and possible mechanisms.
    Heistein LC; Scott WA; Zellers TM; Fixler DE; Ramaciotti C; Journeycake JM; Lemler MS
    Pediatr Cardiol; 2008 Mar; 29(2):285-91. PubMed ID: 17896127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
    Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
    Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of aspirin dosing on platelet function in diabetic and nondiabetic patients: an analysis from the aspirin-induced platelet effect (ASPECT) study.
    DiChiara J; Bliden KP; Tantry US; Hamed MS; Antonino MJ; Suarez TA; Bailon O; Singla A; Gurbel PA
    Diabetes; 2007 Dec; 56(12):3014-9. PubMed ID: 17848625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resistance to low-dose aspirin therapy among patients with acute coronary syndrome in relation to associated risk factors.
    Salama MM; Morad AR; Saleh MA; Sabri NA; Zaki MM; ElSafady LA
    J Clin Pharm Ther; 2012 Dec; 37(6):630-6. PubMed ID: 23121257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
    McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
    Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes.
    Schmugge M; Speer O; Kroiss S; Knirsch W; Kretschmar O; Rand ML; Albisetti M
    Eur J Pediatr; 2015 Jul; 174(7):933-41. PubMed ID: 25589198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thromboxane biosynthesis by triflusal in type 2 diabetes mellitus.
    Falco A; Salvati F; Vitacolonna E; Avellone G; Pinto A; Di Febbo C; Ballone E; Di Nicola M; Ciabattoni G; Davì G
    Atherosclerosis; 2005 Dec; 183(2):329-35. PubMed ID: 16285996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for aspirin resistance in stable coronary artery patients by three different tests.
    Chakroun T; Addad F; Abderazek F; Ben-Farhat M; Hamdi S; Gamra H; Hassine M; Ben-Hamda K; Samama MM; Elalamy I
    Thromb Res; 2007; 121(3):413-8. PubMed ID: 17553552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation between atherosclerosis risk factors and aspirin resistance in a primary prevention population.
    Faraday N; Becker DM; Yanek LR; Herrera-Galeano JE; Segal JB; Moy TF; Bray PF; Becker LC
    Am J Cardiol; 2006 Sep; 98(6):774-9. PubMed ID: 16950183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of VerifyNowR with PlateletMappingR--detected aspirin resistance and correlation with urinary thromboxane.
    Carroll RC; Craft RM; Snider CC; Aligeti VR; Wortham DC
    Anesth Analg; 2013 Feb; 116(2):282-6. PubMed ID: 23302970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin resistance in children and young adults with splenectomized thalassemia diseases.
    Sirachainan N; Wijarn P; Chuansumrit A; Kadegasem P; Wongwerawattanakoon P; Soisamrong A
    Thromb Res; 2015 May; 135(5):916-22. PubMed ID: 25776469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet function recovery after cessation of aspirin: preliminary study of volunteers and surgical patients.
    Zisman E; Erport A; Kohanovsky E; Ballagulah M; Cassel A; Quitt M; Pizov R
    Eur J Anaesthesiol; 2010 Jul; 27(7):617-23. PubMed ID: 20035230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary 11-dehydro-thromboxane B₂ and 2,3-dinor-6-keto-prostaglandin-F₁α in healthy post-menopausal and pre-menopausal women receiving aspirin 100 mg.
    Hartanto MD; Arieselia Z; Setiabudy R; Setiawati A; Baziad A
    J Thromb Thrombolysis; 2012 Jul; 34(1):79-84. PubMed ID: 22311294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine is a novel risk factor for suboptimal response of blood platelets to acetylsalicylic acid in coronary artery disease: a randomized multicenter study.
    Karolczak K; Kamysz W; Karafova A; Drzewoski J; Watala C
    Pharmacol Res; 2013 Aug; 74():7-22. PubMed ID: 23665469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aspirin resistance following pediatric cardiac surgery.
    Cholette JM; Mamikonian L; Alfieris GM; Blumberg N; Lerner NB
    Thromb Res; 2010 Sep; 126(3):200-6. PubMed ID: 20550971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological efficacy of low against medium dose aspirin regimen after coronary surgery: analysis of platelet function.
    Cornelissen J; Kirtland S; Lim E; Goddard M; Bellm S; Sheridan K; Large S; Vuylsteke A
    Thromb Haemost; 2006 Mar; 95(3):476-82. PubMed ID: 16525576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease.
    Lordkipanidzé M; Pharand C; Schampaert E; Turgeon J; Palisaitis DA; Diodati JG
    Eur Heart J; 2007 Jul; 28(14):1702-8. PubMed ID: 17569678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase expression and platelet function in healthy dogs receiving low-dose aspirin.
    Dudley A; Thomason J; Fritz S; Grady J; Stokes J; Wills R; Pinchuk L; Mackin A; Lunsford K
    J Vet Intern Med; 2013; 27(1):141-9. PubMed ID: 23278865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
    Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
    Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.